FDA Approved: INSULIN GLARGINE — Original Application (Biocon Biologics Inc.)

View source ↗

Summary

FDA approved Biocon Biologics Inc.'s insulin glargine biosimilar under an Original Application, expanding access to insulin glargine therapy for people with dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

ORIG AP for INSULIN GLARGINE (INSULIN GLARGINE-YFGN)